ORBIMED ADVISORS LLC - 31 Mar 2026 SCHEDULE 13G/A Report for RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share (RAPT)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: RAPT
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2026, 16:37:34 UTC
Date of event: 31 Mar 2026
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 0% ownership in RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share (RAPT) on 31 Mar 2026."

Quick Takeaways

ORBIMED ADVISORS LLC filed SCHEDULE 13G/A for RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share (RAPT).
Disclosed ownership: 0%.
Date of event: 31 Mar 2026.

What Changed

Previous schedule filing date: 14 Nov 2025.
Current filing was accepted on 15 May 2026, 16:37.

Why This Matters

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	0%	0	0	0	/s/ Carl L. Gordon	Carl L. Gordon/Member

Explore related SEC datasets

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .